Showing 1 - 20 results of 51 for search '(( 200 ns decrease ) OR ( 50 ((((n decrease) OR (a decrease))) OR (_ decrease)) ))~', query time: 0.54s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

    Published 2025
    “…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Identification of +TIPs required for MT plus-end targeting of dynein-dynactin in the <i>C</i>. <i>elegans</i> early embryo. by Daniel J. Barbosa (4288462)

    Published 2017
    “…Image corresponds to a maximum intensity projection over time (10 frames acquired every 200 ms). …”
  11. 11

    Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity. by Daniel J. Barbosa (4288462)

    Published 2017
    “…The N-terminal region of the p150<sup>DNC-1</sup> subunit contains a conserved CAP-Gly domain (residues 1–69) predicted to bind the end-binding homology (EBH) domain of EB and the EEY/F motifs present at the C-termini of EB and α-tubulin. …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Dietary Restriction Induces Gluconeogenic Gene <i>pck-2</i> Expression via DAF-16, and <i>pck-2</i> Expression is Needed for DR-associated Healthspan Benefits. by Brian Onken (86790)

    Published 2020
    “…Disrupting gluconeogenic gene <i>pck-2</i> abolished these beneficial DR effects: animals raised on diluted gluconeogenic RNAi bacteria had survival curves that were not significantly different from those of well-fed animals (n.s., Log-rank). Data are pooled from 2 independent trials, n = 60 animals per condition per trial. ** <i>P</i> < 0.005; n.s. = not significant. …”
  19. 19
  20. 20